stoxline Quote Chart Rank Option Currency Glossary
  
China Pharma Holdings, Inc. (CPHI)
0.2949  0 (0.07%)    05-28 15:58
Open: 0.304
High: 0.304
Volume: 387,527
  
Pre. Close: 0.2947
Low: 0.2801
Market Cap: 5(M)
Technical analysis
2024-05-28 4:21:29 PM
Short term     
Mid term     
Targets 6-month :  0.41 1-year :  0.47
Resists First :  0.35 Second :  0.4
Pivot price 0.31
Supports First :  0.27 Second :  0.22
MAs MA(5) :  0.3 MA(20) :  0.31
MA(100) :  0.39 MA(250) :  0.76
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  8.8 D(3) :  13.2
RSI RSI(14): 40.9
52-week High :  2.2 Low :  0.27
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ CPHI ] has closed above bottom band by 13.7%. Bollinger Bands are 45.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.3 - 0.31 0.31 - 0.31
Low: 0.28 - 0.28 0.28 - 0.28
Close: 0.29 - 0.29 0.29 - 0.3
Company Description

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. was founded in 1993 and is based in Haikou, the People's Republic of China.

Headline News

Mon, 27 May 2024
Financial Analysis: China Pharma Holdings Inc. (CPHI)'s Ratios Unveil Key Insights – DWinneX - The Dwinnex

Wed, 22 May 2024
China Pharma (NYSE:CPHI) Receives New Coverage from Analysts at StockNews.com - Defense World

Sat, 24 Feb 2024
China Pharma Holdings Announces Reverse Stock Split - TipRanks.com - TipRanks

Mon, 29 Jan 2024
Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket - Markets Insider

Fri, 27 Oct 2023
CPHI Annual Report Predicts VC Capital (Re)entry and Contract Services Growth in 2024 - European Pharmaceutical Manufacturer

Wed, 23 Aug 2023
Is China Pharma Holding (CPHI) A Hidden Gem or A Value Trap? - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 33 (M)
Shares Float 18 (M)
Held by Insiders 46.4 (%)
Held by Institutions 0.9 (%)
Shares Short 81 (K)
Shares Short P.Month 44 (K)
Stock Financials
EPS -0.38
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.2
Profit Margin -40 %
Operating Margin -39.6 %
Return on Assets (ttm) -10.9 %
Return on Equity (ttm) -69.6 %
Qtrly Rev. Growth -8.4 %
Gross Profit (p.s.) 0
Sales Per Share 0.23
EBITDA (p.s.) -0.01
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 1 (M)
Stock Valuations
PE Ratio -0.78
PEG Ratio 0
Price to Book value 1.4
Price to Sales 1.24
Price to Cash Flow -104.75
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android